Lymphoma is one of the most common cancers in dogs. Modern chemotherapy protocols offer significant survival benefits, but quality of life throughout treatment is paramount.
Canine lymphoma treatment requires careful quality-of-life consideration at every stage. While CHOP chemotherapy offers meaningful survival extension, treatment burden — including clinic visits, potential nausea, and immunosuppression — must be weighed against benefits. Many dogs maintain excellent quality of life during treatment, but owners should be counseled to monitor closely for suffering. The decision between aggressive treatment, palliative care, and euthanasia should be guided by the individual dog's response and wellbeing, not by owner grief alone.